143 Antibiotic Products with Adjusted Market Approval Specifications

The Korea Food and Drug Administration (KFDA) recently announced a uniform adjustment on the market approval specifications of existing 143 antibiotic products, based on the re-evaluation results on their efficacies, indications, dosages, administrations and precautions.

The 143 products being affected by the announcement are from three antibiotic ingredient categories mixed API (active pha...